Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

10/11/2023 06:00

Nov 10 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2023        Sep 30, 2022      Mar 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln                       
                 (-75.0 pct)         (-31.9 pct)      (-100.0 pct)  
  Operating     loss 550 mln        loss 805 mln        loss 1.35   
  Recurring     loss 551 mln        loss 809 mln        loss 1.35   
  Net           loss 553 mln        loss 810 mln        loss 1.36   
  EPS           loss 8.81 yen      loss 14.20 yen    loss 21.58 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T